ClinicalTrials.Veeva

Menu

Limiting Adverse Birth Outcomes in Resource-Limited Settings (LABOR)

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Birth Outcomes
Labor and Delivery
Respiratory Infection

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT04102644
Z 31902 (Other Identifier)
19-0765

Details and patient eligibility

About

The primary objective of this research is to exhaustively document the course and outcomes of hospitalization, labor, delivery, and early postpartum course of up to 15,000 mother-newborn pairs in settings where the occurrence of adverse outcomes is high. The Investigators will gather detailed laboratory, physiologic, and clinical information, and precisely characterize major adverse diagnoses and outcomes. The resulting high-quality, granular, and generalizable data will be used to develop new algorithms to signal actionable intrapartum diagnoses and prospectively stratify women according to their risk for adverse maternal and neonatal outcomes.

Full description

This is a prospective multi-country cohort study of up to 15,000 women admitted to the hospital for delivery or for management of respiratory infection. Women will be recruited and screened for study participation at the time of presentation to the hospital. Participants will be assessed through hospitalization, labor, delivery, and discharge and at 1- and 6-week postpartum contacts. Liveborn infants will be enrolled at birth and followed through 42 days of life. The pilot phase of this protocol will enroll up to 500 women in labor and their newborns and follow them through labor, delivery, and 42 days postpartum.

Enrollment

12,020 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for women enrolled:

  • Maternal age of majority

  • Intrauterine singleton pregnancy

  • Admission to the hospital for ANY of the following:

    1. vaginal delivery
    2. cesarean delivery in the presence of signs/symptoms of parturition, elevated blood pressure, or fever
    3. management of respiratory infection*
  • Ability and willingness to provide written informed consent

  • Willingness to adhere to study procedures

  • Willingness to provide locator information for follow-up

    • Inclusion of participants admitted to hospital for management of respiratory infection applicable to Zambia site only.

Exclusion Criteria for women enrolled:

  • Admission to the hospital for cesarean delivery in the absence of signs/symptoms of parturition, elevated blood pressure, or fever
  • Any condition (social or medical) that, in the opinion of study staff, would make participation unsafe or not feasible. Study staff may note physical, psychological, or social conditions that are not explicitly stated in the eligibility criteria that could make some women poor candidates for study participation.

Trial design

12,020 participants in 1 patient group

Pregnant Women
Description:
Up to 15,000 pregnant women and their fetuses/newborns (including a pilot phase of up to 500 participant pairs)
Treatment:
Other: Observation

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems